Expert Guidance in Developing Treatment Strategies for Individuals With Unresectable Metastatic Colorectal Cancer

Based on the latest clinical data and guideline recommendations expert faculty highlight first-line and second-line treatment strategies as well as the management of therapeutic toxicities to optimize clinical outcomes for patients with unresectable metastatic colorectal cancer in this series of 3 ClinicalThoughts and associated text module.

Share

Program Content

Activities

Molecular Profiling in CRC
My Thoughts on Molecular Profiling in Colorectal Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2016

Expires: May 02, 2017

Second Line CRC
Biologic Therapies in Metastatic Colorectal Cancer: Mastering Your Moves Beyond First Line
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2016

Expires: June 09, 2017

Toxicities in Refractory Treatment
How I Manage Treatment-Related Toxicity in Refractory Metastatic Colorectal Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2016

Expires: June 30, 2017

Faculty

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech Roche Virology